Target intelligence / Profile preview

Deubiquitinating protein VCPIP1 (VCPIP1)

Target
VCPIP1
Molecular classification
Enzyme, Deubiquitinating enzyme, OTU (ovarian tumor) domain family
01

Overview

Deubiquitinating protein VCPIP1 (VCPIP1) is an **OTU-domain deubiquitinating enzyme** involved in diverse cellular processes, including **protein deubiquitination, DNA-protein cross-link repair, reassembly of the Golgi apparatus and endoplasmic reticulum after mitosis, and protein localization to chromatin**[5]. VCPIP1 interacts with the **valosin-containing protein (VCP/p97), P47, and the SNARE complex** to promote **membrane fusion events** essential for Golgi and ER integrity post-mitosis[1][3]. It can recruit proteasome subunits, such as **PSMC3**, and regulate stability of specific proteins like the **hepatitis B virus X protein (HBx)**, linking it to viral infection and oncogenesis[2][4]. **VCPIP1’s activity spans both enzymatic and scaffolding functions** independent of its DUB activity[2]. Genetic alterations in VCPIP1 or its interacting partners are associated with **cancer, neurodegenerative diseases, and rare genetic syndromes**[5]. While inhibitors targeting VCPIP1 are under investigation, none are currently clinically approved, and the essential nature of its cellular roles suggests a need for caution to avoid disrupting fundamental protein homeostasis[5].

Other names
KIAA1850VCIP135VCP/p47 complex-interacting 135-kDa proteindeubiquitinating protein VCIP135valosin-containing protein p97/p47 complex-interacting protein 1VCP/p47 complex-interacting protein p135DUBA3FLJ23132
02

Mechanism of action

Drugs targeting deubiquitinating enzymes often act by inhibiting or modulating enzymatic deubiquitination activity, but specific mechanism for direct VCPIP1 modulators not established as of current knowledge[2][5].

03

Biological functions

Protein deubiquitinationDNA-protein cross-link repairGolgi apparatus and endoplasmic reticulum reassembly after mitosisRegulation of protein localization to chromatinRegulation of membrane fusion (Golgi and ER)
04

Disease associations

Cancer (notably hepatocellular carcinoma via hepatitis B virus X protein stabilization)Infection (role in hepatitis B virus, Clostridium botulinum neurotoxin action)Neurodegenerative disease (implicated via associated diseases like Inclusion Body Myopathy with Paget Disease of Bone and Frontotemporal Dementia)Other (Ruijs-Aalfs Syndrome)
05

Safety considerations

Targeting deubiquitinases may affect essential cellular processes (e.g., protein degradation, genome stability, membrane dynamics)Loss or excessive activity could lead to cellular dysfunction, increased infection risk, or impaired DNA repair

Beyond the preview

Go deeper on Deubiquitinating protein VCPIP1 (VCPIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deubiquitinating protein VCPIP1 (VCPIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call